News

Two sides to overcoming antibiotic resistance

Researchers seeking new classes of chemical compounds or pursuing alternative antibacterial approaches make their cases.
Written bySarah Anderson, PhD
| 6 min read
A white bottle spills colorful pills in the shape of a question mark on a yellow surface.

Antimicrobial resistance throws the efficacy of antibiotics into question.

credit: istock/bong hyunjung

Bacteria have persisted on Earth for billions of years, first emerging in the oxygen-starved waters of the early oceans. Today, bacteria continue to thrive in a range of harsh environments, from bubbling hot springs to Arctic ice to the human body, where certain bacteria cause infection. Ever adaptable, these bacteria undergo mutations that allow them to resist the effects of antibiotic drugs. “Antibiotic resistance is a matter of evolution,” said Rolf Müller, a chemical microbiologist at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). “It's not a matter of if; it's just a matter of when.”

“Anything you throw at [bacteria] provides a selection for a mutation that's likely to make them able to grow in the presence of that new antibiotic,” said Bob Hancock, a microbiologist and immunologist at the University of British Columbia. “Bacteria become resistant to virtually everything.”

While the development of antibiotic resistance is inevitable, antibiotic misuse and overuse have accelerated resistance, yielding a major threat to human health. With projected death tolls from resistant infections comparable to that of the COVID-19 pandemic, it is critical to find alternate ways to take down bacteria (1). Müller is one of a group of researchers identifying chemical compounds in natural sources that kill bacteria through new mechanisms. Hancock is among researchers developing noncompound alternatives to antibiotics that can both directly and indirectly target bacteria. While they represent two schools of thought, both researchers agree that the two approaches could be used together to attack evasive bacteria from every angle.

No soil left unturned

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

  • Sarah Anderson, PhD

    Sarah Anderson joined Drug Discovery News as an assistant editor in 2022. She earned her PhD in chemistry and master’s degree in science journalism from Northwestern University. She served as managing editor of the Illinois Science Council’s “Science Unsealed” blog and has written for Discover Magazine, Astronomy Magazine, Chicago Health Magazine, and others. She enjoys reading at the beach, listening to Taylor Swift, and cuddling her cat, Augustus.

    View Full Profile

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D molecular visualization of a protein structure, rendered in a ribbon diagram style.
A comparative structural analysis of MC4R complexes reveals how agonist binding influences receptor conformation, ligand interactions, and complex stability.
Gloved hand holding a multiwell cell culture plate under a fluorescence microscope for spheroid analysis.
Using confocal live-cell imaging to characterize immune-mediated cytotoxicity over time.
Fluorescence microscopy image of cells displaying green and red fluorescent signals.
Using confocal live-cell imaging to assess treatment effects in spheroids, organoids, and co-cultures.